2000
DOI: 10.1016/s0264-410x(00)00035-9
|View full text |Cite
|
Sign up to set email alerts
|

Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
49
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 82 publications
(55 citation statements)
references
References 50 publications
6
49
0
Order By: Relevance
“…Whole coding sequence of GRA4 has been tried as a DNA vaccine, which results in a 62% survival of susceptible C57BL/6 infected mice [44]. Vaccine efficacy of recombinant GRA4 (rGRA4) and ROP2 (rRPO2) proteins and a mix of both combined with alum is evaluated in C57BL/6 and C3H mice [45].…”
Section: Gra4mentioning
confidence: 99%
“…Whole coding sequence of GRA4 has been tried as a DNA vaccine, which results in a 62% survival of susceptible C57BL/6 infected mice [44]. Vaccine efficacy of recombinant GRA4 (rGRA4) and ROP2 (rRPO2) proteins and a mix of both combined with alum is evaluated in C57BL/6 and C3H mice [45].…”
Section: Gra4mentioning
confidence: 99%
“…Although DNA immunization can elicit some degree of protective immunity, the activation of specific CD8 T cells has been poorly or not at all characterized (Nielsen et al 1999, Angus et al 2000, Vercammen et al 2000, Desolme et al 2000. Whether subunit vaccines may induce protective CD8 T cells specific for these antigen remains to be further characterized in the future.…”
Section: Toxoplasma Gondii and Leishmania Spmentioning
confidence: 99%
“…Numerous studies have evaluated responses to vaccines based on protein or DNA components of T. gondii with various degrees of success (1,2,4,5,9,11,22,24,25,28,36,37,40,44,46). Virulent parasite strains, as well as attenuated T. gondii strains, have been paramount in dissecting the immunobiology of host response in regard to understanding adaptive immune responses that may be helpful in vaccine design.…”
mentioning
confidence: 99%